Clinical Trial Update: Study of Tumor RNA Disruption Assay™ (RDA) [NA]

View source ↗

Summary

A clinical trial evaluating the Tumor RNA Disruption Assay (RDA) for breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Toronto | Conditions: Breast Neoplasms | NA | Status: TERMINATED